Valuation (64%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 90.17 | N/A |
| PEG Ratio (TTM) | 10.82 | N/A |
| P/S Ratio (TTM) | 1.60 | N/A |
| P/B Ratio (TTM) | 2.86 | N/A |
| P/FCF Ratio (TTM) | 19.47 | N/A |
| Price to 5YR AVG Earnings Ratio | 26.16 | N/A |
| Price to 5YR AVG FCF Ratio | 16.31 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.15% | N/A |
| ROE (TTM) | 3.21% | N/A |
| Net Profit Margin (TTM) | 1.72% | N/A |
| ROIC 5YR AVG | 8.96% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -25.61% | -18.13% | 1.50% |
| Revenue | 0.02% | -0.95% | 0.80% |
| Net Income | -17.43% | -16.28% | 7.11% |
| Cash Flow | 55.47% | 5.94% | 3.76% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.10 | N/A |
| Quick Ratio (TTM) | 1.10 | N/A |
| D/E Ratio (TTM) | 1.29 | N/A |
| Interest Coverage (TTM) | 1.67 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.92 | N/A |
| LTL to 5YR AVG FCF | 7.62 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.28% | N/A |